Skip to main content
. 2018 Feb 1;32(3-4):224–229. doi: 10.1101/gad.306464.117

Figure 5.

Figure 5.

The BET inhibitor affects S-phase progression. (A) BRD4 and TICRR immunoblots after MZ1 or cis-MZ1 treatment of U2OS cells for the indicated times. (BD) Synchronized U2OS cells were released into S phase with 1 µM MZ1 or cis-MZ1 and harvested at the indicated times for FACS DNA content analysis (B), spatiotemporal replication pattern scoring (C), or S-phase exit (D). DNA replication foci were detected using PCNA immunofluorescence in C and D.